Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 12 Nov 20 424B3 Prospectus supplement
- 10 Nov 20 EFFECT Notice of effectiveness
- 5 Nov 20 POS AM Prospectus update (post-effective amendment)
- 10 Sep 20 424B3 Prospectus supplement
- 14 Aug 20 424B3 Prospectus supplement
- 5 Aug 20 424B3 Prospectus supplement
- 26 Jun 20 424B3 Prospectus supplement
- 27 May 20 424B3 Prospectus supplement
- 13 May 20 424B3 Prospectus supplement
- 12 May 20 EFFECT Notice of effectiveness
- 11 May 20 424B3 Prospectus supplement
-
4 May 20 S-1 IPO registration
DMTKQ similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
DermTech, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus. Our report also refers to the adoption of Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606), as amended.
/s/ KPMG LLP |
San Diego, California |
May 4, 2020 |